In addition, MAPT can alter the characteristics of the glioma mesenchyme by inhibiting EGFR-mediated NF- κB and TAZ signaling pathways, inhibit the transformation of tumor cells into pericytes, normalize tumor blood vessels, and reduce the invasiveness of gliomas (Gargini et al., 2020). Here, EGFR is linked to glioma.